John Frazer

556 total citations
15 papers, 361 citations indexed

About

John Frazer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, John Frazer has authored 15 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in John Frazer's work include Receptor Mechanisms and Signaling (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuropeptides and Animal Physiology (3 papers). John Frazer is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuropeptides and Animal Physiology (3 papers). John Frazer collaborates with scholars based in United States and France. John Frazer's co-authors include David J. Unett, William Thomsen, Ibragim Gaidarov, Joel Gatlin, Todd L. Anthony, Graeme Semple, John W. Adams, Xiaohua Chen, Charles Xing and Daniel J. Buzard and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

John Frazer

15 papers receiving 348 citations

Peers

John Frazer

CMN

CCM

RNMI

PHARM

Jonas Hansen Denmark

Birendra Pramanik United States

Mylène Gosselin Canada

Liaman Mamedova United States

Shinichiro Atsumi Japan

Jan Møller Germany

Laerte Oliveira Brazil

Heng B. See Australia

Chamila N. Rupasinghe United States

Elizabeth K. M. Johnstone Australia

Jonas Hansen Denmark

John Frazer

351 ×1.5

158 ×1.6

CMN

75 ×1.6

CCM

59 ×1.5

RNMI

19 ×0.6

PHARM

Citations per year, relative to John Frazer John Frazer (= 1×) peers Jonas Hansen

Countries citing papers authored by John Frazer

Since Specialization

Citations

This map shows the geographic impact of John Frazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Frazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Frazer more than expected).

Fields of papers citing papers by John Frazer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Frazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Frazer. The network helps show where John Frazer may publish in the future.

Co-authorship network of co-authors of John Frazer

This figure shows the co-authorship network connecting the top 25 collaborators of John Frazer. A scholar is included among the top collaborators of John Frazer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Frazer. John Frazer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gaidarov, Ibragim, John Frazer, Xiaohua Chen, et al.. (2025). Mechanisms of constitutive and agonist-induced 5-HT2B internalization, persistent endosomal signaling and paradoxical regulation of agonist pharmacology. Cellular Signalling. 131. 111769–111769. 2 indexed citations

Ren, Albert, Xiuwen Zhu, Juerg Lehmann, et al.. (2025). Diazepine Agonists of the 5-HT_2C Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352). Journal of Medicinal Chemistry. 68(11). 10599–10618. 2 indexed citations

Ren, Albert, Xiuwen Zhu, Konrad Feichtinger, et al.. (2019). Discovery of a lead series of potent benzodiazepine 5-HT2C receptor agonists with high selectivity in functional and binding assays. Bioorganic & Medicinal Chemistry Letters. 30(5). 126929–126929. 3 indexed citations

Gaidarov, Ibragim, John W. Adams, John Frazer, et al.. (2018). Angiotensin (1–7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor. Cellular Signalling. 50. 9–24. 40 indexed citations

Unett, David J., Joel Gatlin, Todd L. Anthony, et al.. (2013). Kinetics of 5-HT2B Receptor Signaling: Profound Agonist-Dependent Effects on Signaling Onset and Duration. Journal of Pharmacology and Experimental Therapeutics. 347(3). 645–659. 45 indexed citations

Ullman, Brett R., Konrad Feichtinger, John Frazer, et al.. (2012). Identification of fused bicyclic heterocycles as potent and selective 5-HT2A receptor antagonists for the treatment of insomnia. Bioorganic & Medicinal Chemistry Letters. 22(5). 1870–1873. 9 indexed citations

Semple, Graeme, Vincent J. Santora, Jeffrey M. Smith, et al.. (2011). Identification of biaryl sulfone derivatives as antagonists of the histamine H3 receptor: Discovery of (R)-1-(2-(4′-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916). Bioorganic & Medicinal Chemistry Letters. 22(1). 71–75. 11 indexed citations

Xiong, Yifeng, Brett R. Ullman, Peter I. Dosa, et al.. (2010). Synthesis and in Vivo Evaluation of Phenethylpiperazine Amides: Selective 5-Hydroxytryptamine_2AReceptor Antagonists for the Treatment of Insomnia. Journal of Medicinal Chemistry. 53(15). 5696–5706. 6 indexed citations

Ramirez, Juan Ignacio, Yunqing Shi, William Thomsen, et al.. (2009). APD791, 3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a Novel 5-Hydroxytryptamine 2A Receptor Antagonist: Pharmacological Profile, Pharmacokinetics, Platelet Activity and Vascular Biology. Journal of Pharmacology and Experimental Therapeutics. 331(1). 96–103. 17 indexed citations

10.

Santora, Vincent J., Jonathan A. Covel, Michael I. Weinhouse, et al.. (2008). Novel H3 receptor antagonists with improved pharmacokinetic profiles. Bioorganic & Medicinal Chemistry Letters. 18(14). 4133–4136. 4 indexed citations

11.

Thomsen, William, John Frazer, & David J. Unett. (2005). Functional assays for screening GPCR targets. Current Opinion in Biotechnology. 16(6). 655–665. 178 indexed citations

12.

Wilson, George S., et al.. (1994). Enhanced immunogenicity of leucine enkephalin following coupling to anti-immunoglobulin and anti-CD3 antibodies. Journal of Immunological Methods. 172(2). 165–172. 1 indexed citations

13.

Frazer, John, et al.. (1985). Plasma protein and liver mRNA levels of two closely related murine α1-protease inhibitors during the acute phase reaction. Archives of Biochemistry and Biophysics. 239(1). 112–119. 8 indexed citations

14.

Finlay, Thomas H., Susan Kadner, Salim Nathoo, et al.. (1983). EFFECTS OF DETERGENTS ON THE ACTIVITY OF α₂‐MACROGLOBULIN‐PROTEASE COMPLEXES^a. Annals of the New York Academy of Sciences. 421(1). 340–351. 1 indexed citations

15.

Frazer, John, et al.. (1972). Isoaccepting transfer ribonucleic acids in liver and brain of young and old BC3F1 mice. Archives of Biochemistry and Biophysics. 153(2). 610–618. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact